Drugstore operator CVS Caremark (NYSE:CVS) announced third quarter earnings growth of 7% over the 2010 quarter. In addition, the company forecasted a more favorable 2011 driven by growth in the number of pharmacy claims the company processed. A solid quarter and a forecast for an even better year, should be the beginning of a quality growth cycle for CVS.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

Future Growth Ahead
CVS reported a net income of $868 million, or 65 cents a share, compared with a net income of $809 million, or 59 cents a share, in the year ago 2010 period. Analysts were expecting earnings of 67 cents, not accounting for expenses related to acquisitions. Absent those expenses, CVS could be earning 70 cents per share. Profit growth was accompanied by a healthy 12% increase in sales quarter over quarter. CVS benefited from strong growth in its pharmacy benefits business, fueled by the acquisitions of Caremark and the Medicare business from Universal American. Those acquisitions have enabled CVS to directly negotiate lower prescription prices with drug manufacturers. Caremark is expected to add over $8 billion in top line growth in 2011, while the Universal American deal will add over $5 billion in sales in 2012. The company's retail drugstores grew sales by 4% quarter over quarter, while same-store sales, the true measure of retailing health, grew 2.3%, respectively. As the pharmacy business fuels prescription growth, increased store traffic should fuel drugstore growth. (For related reading, see Consumer Spending As A Market Indicator.)

Recession Proof Business
CVS is the second largest drugstore chain operator in the U.S. The largest is rival Walgreen (NYSE:WAG). Together, CVS and WAG operate in a near duopolistic industry. Much smaller rival, Rite-Aid (NYSE:RAD) has been struggling under a pile of debt. CVS currently has over 7,300 locations, while Walgreen's operates over 8,200 locations. Rite-Aid's 4,700 stores would make a decent acquisition, except for the fact that company sits on over $6 billion in debt. Moreover, CVS has been building new locations and taking advantage of cheaper building and construction costs.

With the U.S. population aging, prescription drug demand is expected to grow for years. As CVS continues to benefit from the growth, in its pharmacy benefits business, the company's top and bottom line will likely continue to grow. For 2012, the analysts expect earnings per share of $3.18, but could very likely exceed that guidance. Low prices from Wal-Mart (NYSE:WMT) is not a threat, since CVS can sell generics at the same price. The edge that CVS and Walgreen's have over Wal-Mart is that they have smaller stores, which are often a shorter driving distance than the nearest Wal-Mart. The convenience factor is a valuable one.

The Bottom Line
Trading at about 15 times trailing earnings, CVS has a very reasonable valuation for such a solid business. Prescription drug demand is growing due to a growing aging population. Healthcare is not an economically sensitive product, and will not be drastically affected by any economic setbacks. That gives the company resilience in an uncertain economy. (For related reading, see How To Do Qualitative Analysis On Biotech Companies.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Sham Gad did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    Allstate: How Being Boring Earns it Billions (ALL)

    A summary of what Allstate Insurance sells and whom it sells it to including recent mergers and acquisitions that have helped boost its bottom line.
  2. Options & Futures

    Cyclical Versus Non-Cyclical Stocks

    Investing during an economic downturn simply means changing your focus. Discover the benefits of defensive stocks.
  3. Investing Basics

    How to Deduct Your Stock Losses

    Held onto a stock for too long? Selling at a loss is never ideal, but it is possible to minimize the damage. Here's how.
  4. Economics

    Is Wall Street Living in Denial?

    Will remaining calm and staying long present significant risks to your investment health?
  5. Stock Analysis

    When Will Dick's Sporting Goods Bounce Back? (DKS)

    Is DKS a bargain here?
  6. Investing News

    How AT&T Evolved into a Mobile Phone Giant

    A third of Americans use an AT&T mobile phone. How did it evolve from a state-sponsored monopoly, though antitrust and a technological revolution?
  7. Stock Analysis

    Home Depot: Can its Shares Continue Climbing?

    Home Depot has outperformed the market by a wide margin in the last 12 months. Is this sustainable?
  8. Stock Analysis

    Yelp: Can it Regain its Losses in 2016? (YELP)

    Yelp investors have had reason to be happy recently. Will the good spirits last?
  9. Stock Analysis

    Is Walmart's Rally Sustainable? (WMT)

    Walmart is enjoying a short-term rally. Is it sustainable? Is Amazon still a better bet?
  10. Stock Analysis

    GoPro's Stock: Can it Fall Much Further? (GPRO)

    As a company that primarily sells discretionary products, GoPro and its potential falls right in line with consumer trends. Is that good or bad?
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

Trading Center